Amr Muhammad Abdo Salem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amr Muhammad Abdo Salem has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Allam El-Sayed Allam
Department of diagnostic & interventional radiology and molecular imaging, faculty of medicine, Ain Shams University, Cairo, Egypt
2 shared publicationsLaila Hosny Hussein
Department of diagnostic & interventional radiology and molecular imaging, faculty of medicine, Ain Shams University, Cairo, Egypt
2 shared publicationsMohamed El-Gharib Abou-Elmaaty
Department of diagnostic & interventional radiology and molecular imaging, faculty of medicine, Ain Shams University, Cairo, Egypt
2 shared publicationsMohamed Gamal Abdelmoteleb
Department of diagnostic & interventional radiology and molecular imaging, faculty of medicine, Ain Shams University, Cairo, Egypt
2 shared publicationsAhmed Mohamed Osman
Radiology Department-faculty of Medicine-Ain Shams University, Cairo, Egypt
1 shared publication- Ahmed Mohamed Osman
Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 16 June 2025
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 56 (1) , 1-8
Ultrasound (US)-guided ethanol ablation for cystic thyroid nodules: a comparison of the ethanol retention and aspiration techniques
Purpose: This study evaluates the efficacy and safety of ethanol ablation for cystic thyroid nodules by comparing the retention and aspiration techniques. Methods: A prospective randomized trial was conducted from November 2021 to August 2022, involving 60 patients (mean age 38.83 ± 11.86 years) with thyroid cysts or predominantly cystic nodules. Patients were divided into two groups of 30 each: one treated using the retention technique and the other using the aspiration technique. Females constituted 73.3% of participants (44 patients). The study assessed nodules classified as purely cystic (43.3%) or predominantly cystic (56.7%). Results: The median initial nodule volume was 29.5 cc (20.25–39.5). After 12 months, the median volume reduction ratio (VRR) was 79.5% (63–86), with an overall success rate of 83.33% (VRR ≥ 50%). Both techniques yielded comparable results for VRR (P = 0.379), success rates (P = 0.731), symptom scores (P = 0.617), cosmetic outcomes (P = 0.289), and procedural pain (P = 0.526). Factors such as initial nodule volume and solid component percentage were inversely correlated with VRR (P < 0.001 and P = 0.037, respectively). Lower success rates were observed in nodules with type 2 or 3 vascularity compared to those with type 0 or 1 vascularity (P < 0.001). Conclusion: Both retention and aspiration techniques are effective and safe for managing cystic and predominantly cystic thyroid nodules. The outcomes of ethanol ablation are influenced by factors such as initial volume, solid component percentage, and nodule vascularity.
- 16 June 2025
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 56 (1) , 1-8
Open AccessUltrasound (US)-guided ethanol ablation for cystic thyroid nodules: a comparison of the ethanol retention and aspiration techniques
Purpose: This study evaluates the efficacy and safety of ethanol ablation for cystic thyroid nodules by comparing the retention and aspiration techniques. Methods: A prospective randomized trial was conducted from November 2021 to August 2022, involving 60 patients (mean age 38.83 ± 11.86 years) with thyroid cysts or predominantly cystic nodules. Patients were divided into two groups of 30 each: one treated using the retention technique and the other using the aspiration technique. Females constituted 73.3% of participants (44 patients). The study assessed nodules classified as purely cystic (43.3%) or predominantly cystic (56.7%). Results: The median initial nodule volume was 29.5 cc (20.25–39.5). After 12 months, the median volume reduction ratio (VRR) was 79.5% (63–86), with an overall success rate of 83.33% (VRR ≥ 50%). Both techniques yielded comparable results for VRR (P = 0.379), success rates (P = 0.731), symptom scores (P = 0.617), cosmetic outcomes (P = 0.289), and procedural pain (P = 0.526). Factors such as initial nodule volume and solid component percentage were inversely correlated with VRR (P < 0.001 and P = 0.037, respectively). Lower success rates were observed in nodules with type 2 or 3 vascularity compared to those with type 0 or 1 vascularity (P < 0.001). Conclusion: Both retention and aspiration techniques are effective and safe for managing cystic and predominantly cystic thyroid nodules. The outcomes of ethanol ablation are influenced by factors such as initial volume, solid component percentage, and nodule vascularity.
- Top Cited PapersOpen Access
- 19 March 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-14
A large-scale multicenter breast cancer DCE-MRI benchmark dataset with expert segmentations
Artificial Intelligence (AI) research in breast cancer Magnetic Resonance Imaging (MRI) faces challenges due to limited expert-labeled segmentations. To address this, we present a multicenter dataset of 1506 pre-treatment T1-weighted dynamic contrast-enhanced MRI cases, including expert annotations of primary tumors and non-mass-enhanced regions. The dataset integrates imaging data from four collections in The Cancer Imaging Archive (TCIA), where only 163 cases with expert segmentations were initially available. To facilitate the annotation process, a deep learning model was trained to produce preliminary segmentations for the remaining cases. These were subsequently corrected and verified by 16 breast cancer experts (averaging 9 years of experience), creating a fully annotated dataset. Additionally, the dataset includes 49 harmonized clinical and demographic variables, as well as pre-trained weights for a baseline nnU-Net model trained on the annotated data. This resource addresses a critical gap in publicly available breast cancer datasets, enabling the development, validation, and benchmarking of advanced deep learning models, thus driving progress in breast cancer diagnostics, treatment response prediction, and personalized care.
- 19 March 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-14
Top Cited PapersOpen AccessA large-scale multicenter breast cancer DCE-MRI benchmark dataset with expert segmentations
Artificial Intelligence (AI) research in breast cancer Magnetic Resonance Imaging (MRI) faces challenges due to limited expert-labeled segmentations. To address this, we present a multicenter dataset of 1506 pre-treatment T1-weighted dynamic contrast-enhanced MRI cases, including expert annotations of primary tumors and non-mass-enhanced regions. The dataset integrates imaging data from four collections in The Cancer Imaging Archive (TCIA), where only 163 cases with expert segmentations were initially available. To facilitate the annotation process, a deep learning model was trained to produce preliminary segmentations for the remaining cases. These were subsequently corrected and verified by 16 breast cancer experts (averaging 9 years of experience), creating a fully annotated dataset. Additionally, the dataset includes 49 harmonized clinical and demographic variables, as well as pre-trained weights for a baseline nnU-Net model trained on the annotated data. This resource addresses a critical gap in publicly available breast cancer datasets, enabling the development, validation, and benchmarking of advanced deep learning models, thus driving progress in breast cancer diagnostics, treatment response prediction, and personalized care.
- 1 October 2024
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 117 (Supplement)
Comparison of the Retention and Aspiration Techniques in Ultrasound-Guided Ethanol Ablation of Thyroid Cystic Nodules
Background: Ethanol ablation (EA) is the first-line of therapy for relapsing symptomatic cystic thyroid nodules in most guidelines; however there is no consensus regarding the procedure details. Two techniques have been described for EA of thyroid cystic nodules; the retention technique and the aspiration technique. There are conflicting data regarding the superiority of one technique over the other. Aim of the Work: to compare between the retention technique and the aspiration technique in treating cystic and predominantly cystic thyroid nodules. Patients and Methods: 20 patients with mean age of 35.3±15.2 years having thyroid cysts or predominantly cystic nodules were treated using ethanol ablation. 10 patients were treated using retention technique, the other 10 patients were treated using aspiration technique. Results: 15 patients (75%) were females, while 5 patients (25%) were males. Pure cystic nodules were 9 (45%), while 11 (55 %) patients had predominantly cystic nodules. The median nodule initial volume was 26 cc (14.23-38.45). The 6 month VRR was 81% (60-88), with overall success rate (VRR≥ 50%) of 85 %. No statistically significant difference was found between the retention and aspiration techniques as regards the 6-month VRR (P = 0.62), success rate (P = 0.76), symptom score (P = 0.63), cosmetic score (P = 0.455), or procedural pain (P = 0.43). Conclusion: Retention and aspiration techniques show the same efficacy and safety in treating pure cystic and predominantly cystic thyroid nodules.
- 1 October 2024
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 117 (Supplement)
Comparison of the Retention and Aspiration Techniques in Ultrasound-Guided Ethanol Ablation of Thyroid Cystic Nodules
Background: Ethanol ablation (EA) is the first-line of therapy for relapsing symptomatic cystic thyroid nodules in most guidelines; however there is no consensus regarding the procedure details. Two techniques have been described for EA of thyroid cystic nodules; the retention technique and the aspiration technique. There are conflicting data regarding the superiority of one technique over the other. Aim of the Work: to compare between the retention technique and the aspiration technique in treating cystic and predominantly cystic thyroid nodules. Patients and Methods: 20 patients with mean age of 35.3±15.2 years having thyroid cysts or predominantly cystic nodules were treated using ethanol ablation. 10 patients were treated using retention technique, the other 10 patients were treated using aspiration technique. Results: 15 patients (75%) were females, while 5 patients (25%) were males. Pure cystic nodules were 9 (45%), while 11 (55 %) patients had predominantly cystic nodules. The median nodule initial volume was 26 cc (14.23-38.45). The 6 month VRR was 81% (60-88), with overall success rate (VRR≥ 50%) of 85 %. No statistically significant difference was found between the retention and aspiration techniques as regards the 6-month VRR (P = 0.62), success rate (P = 0.76), symptom score (P = 0.63), cosmetic score (P = 0.455), or procedural pain (P = 0.43). Conclusion: Retention and aspiration techniques show the same efficacy and safety in treating pure cystic and predominantly cystic thyroid nodules.
- Open Access
- 6 May 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-10
FDG-PET/CT tumor to liver SUV ratio (TLR), tumor SUVmax, and tumor size: can this help in differentiating squamous cell carcinoma from adenocarcinoma of the lung?
Background: PET/CT plays an essential role in the diagnosis, staging, and follow-up of lung cancer. We aimed to assess the ability of PET/CT to differentiate between adenocarcinomas (AC) and squamous cell carcinomas (SCC) of the lung using tumor size, tumor maximum standardized uptake value (SUVmax), lymph nodes SUVmax, and tumor to liver SUV ratio (TLR). Results: A total of 60 patients pathologically proved to have non-small cell lung cancer either AC or SCC were retrospectively evaluated. The mean tumor size, SUVmax of the tumor, and TLR were significantly higher in SCC lesions compared to AC lesions. The mean SCC tumoral size was 7.96 ± 2.18 cm compared to 5.66 ± 2.57 cm in AC lesions (P = 0.008). The mean tumor SUVmax in SCC lesions was 18.95 ± 8.3 compared to 12.4 ± 7.55 in AC lesions (P = 0.04). While the mean TLR of SCC lesions was 10.32 ± 4.03 compared to 7.36 ± 4.61 in AC lesions (P = 0.028). All three parameters showed the same sensitivity (75%), while TLR showed the highest specificity (77.78%) followed by tumor size (76.47%) and then SUVmax of the tumor (72.22%). Conclusions: SCC of the lung has a higher mean tumor size, SUVmax of the tumor, and TLR as compared to AC which can be helpful tools in differentiation between them using PET/CT.
- 6 May 2022
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 53 (1) , 1-10
Open AccessFDG-PET/CT tumor to liver SUV ratio (TLR), tumor SUVmax, and tumor size: can this help in differentiating squamous cell carcinoma from adenocarcinoma of the lung?
Background: PET/CT plays an essential role in the diagnosis, staging, and follow-up of lung cancer. We aimed to assess the ability of PET/CT to differentiate between adenocarcinomas (AC) and squamous cell carcinomas (SCC) of the lung using tumor size, tumor maximum standardized uptake value (SUVmax), lymph nodes SUVmax, and tumor to liver SUV ratio (TLR). Results: A total of 60 patients pathologically proved to have non-small cell lung cancer either AC or SCC were retrospectively evaluated. The mean tumor size, SUVmax of the tumor, and TLR were significantly higher in SCC lesions compared to AC lesions. The mean SCC tumoral size was 7.96 ± 2.18 cm compared to 5.66 ± 2.57 cm in AC lesions (P = 0.008). The mean tumor SUVmax in SCC lesions was 18.95 ± 8.3 compared to 12.4 ± 7.55 in AC lesions (P = 0.04). While the mean TLR of SCC lesions was 10.32 ± 4.03 compared to 7.36 ± 4.61 in AC lesions (P = 0.028). All three parameters showed the same sensitivity (75%), while TLR showed the highest specificity (77.78%) followed by tumor size (76.47%) and then SUVmax of the tumor (72.22%). Conclusions: SCC of the lung has a higher mean tumor size, SUVmax of the tumor, and TLR as compared to AC which can be helpful tools in differentiation between them using PET/CT.
- 1 October 2021
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 114 (Supplement)
Role of FDG-PET CT in differentiating adenocarcinomas from squamous cell carcinomas of the lung
Background: Lung cancer is the leading cause of cancer related deaths worldwide. The combination of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) has a great impact on the diagnosis, staging, and hence on the treatment plan and follow up of lung cancer patients. Maximum standardized uptake value (SUVmax) is a semi-quantitative index which is easily performed and the most widely used quantitative parameter for the analysis of 18F-FDG PET images and for the estimation of metabolic activity. Objective: to investigate the role of PET/ CT to differentiate between adenocarcinomas (AC) and squamous cell carcinomas (SCC) as the most common lung cancer by comparing their FDG uptake measured in the form of SUVmax. Methods: A retrospective observational study, conducted at Ain Shams University Hospitals- Radiology Department patients diagnosed with non-small cell lung cancer (NSCLC) and histopathologically proved to be adenocarcinoma or squamous cell carcinoma. All were investigated using PET/CT scans in the period between June 2017 to September 2019. SUVmax of the lesion were measured and statistically analyzed compared with the histopathological type. Results: A total of 30 patients were evaluated with the age ranging from 31 to 81 years old, the mean was 56.9 years (SD ± 11.53). Among them 25 patients (83.3%) were males and 5 patients (16.7%) were females. Out of the 30 NSCLC patients included in the study, 18 patients (60%) were histopathologically diagnosed as AC and 12 patients (40%) were histopathologically diagnosed as SCC. The mean SUVmax of the 30 NSCLC lesions was 15.02±8.4 (range: 2-32.8).The mean SUVmax of AC lesions was 12.4±7.55 (range: 2-32.8), while the mean SUVmax of SCC lesions was 18.95±8.3 (range: 3.7-30.77). The mean SUVmax of lesions in patients with SCC was significantly higher than that of patients with AC using Wilcoxon-Mann-Whitney test (P = 0.04). Conclusion: SCC of the lung has higher SUVmax than AC of the lung and it can be used to differentiate between them using PET/CT.
- 1 October 2021
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 114 (Supplement)
Role of FDG-PET CT in differentiating adenocarcinomas from squamous cell carcinomas of the lung
Background: Lung cancer is the leading cause of cancer related deaths worldwide. The combination of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) has a great impact on the diagnosis, staging, and hence on the treatment plan and follow up of lung cancer patients. Maximum standardized uptake value (SUVmax) is a semi-quantitative index which is easily performed and the most widely used quantitative parameter for the analysis of 18F-FDG PET images and for the estimation of metabolic activity. Objective: to investigate the role of PET/ CT to differentiate between adenocarcinomas (AC) and squamous cell carcinomas (SCC) as the most common lung cancer by comparing their FDG uptake measured in the form of SUVmax. Methods: A retrospective observational study, conducted at Ain Shams University Hospitals- Radiology Department patients diagnosed with non-small cell lung cancer (NSCLC) and histopathologically proved to be adenocarcinoma or squamous cell carcinoma. All were investigated using PET/CT scans in the period between June 2017 to September 2019. SUVmax of the lesion were measured and statistically analyzed compared with the histopathological type. Results: A total of 30 patients were evaluated with the age ranging from 31 to 81 years old, the mean was 56.9 years (SD ± 11.53). Among them 25 patients (83.3%) were males and 5 patients (16.7%) were females. Out of the 30 NSCLC patients included in the study, 18 patients (60%) were histopathologically diagnosed as AC and 12 patients (40%) were histopathologically diagnosed as SCC. The mean SUVmax of the 30 NSCLC lesions was 15.02±8.4 (range: 2-32.8).The mean SUVmax of AC lesions was 12.4±7.55 (range: 2-32.8), while the mean SUVmax of SCC lesions was 18.95±8.3 (range: 3.7-30.77). The mean SUVmax of lesions in patients with SCC was significantly higher than that of patients with AC using Wilcoxon-Mann-Whitney test (P = 0.04). Conclusion: SCC of the lung has higher SUVmax than AC of the lung and it can be used to differentiate between them using PET/CT.